DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. The company's immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips to automate microplate based assays; and ETI Max 3000, an automated microtiter plate analyzer. It also offers molecular diagnostic products LIAISON MDX a thermocycler; and LIAISON IAM, an instrument for amplification of nucleic acids, as well as kits, PCR master mixes, primer pairs, and molecular controls for monitoring oncology and infectious diseases. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, North Americam Central America, South America, and the Asia Pacific. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.
Industry, Sector and Symbol
Industry Private households
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone390-161-4871
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees1,861
Next Earnings DateN/A
OptionableNot Optionable
DiaSorin (OTCMKTS:DSRLF) Frequently Asked Questions
What is DiaSorin's stock symbol?
DiaSorin trades on the OTCMKTS under the ticker symbol "DSRLF."
Has DiaSorin been receiving favorable news coverage?
Press coverage about DSRLF stock has been trending somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. DiaSorin earned a news impact score of 1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for DiaSorin.
Who are some of DiaSorin's key competitors?
Some companies that are related to DiaSorin include UniCredit (UNCFF), SAMPO OYJ/ADR (SAXPY), HENNES & MAURIT/ADR (HNNMY), ATLAS COPCO AB/S (ATLKY), ASSD BRIT FOODS/ADR (ASBFY), ASSA ABLOY AB/S (ASAZY), SMC CORP JAPAN/S (SMCAY), A P MOLLER-MAER/ADR (AMKBY), MICHELIN COMPAG/ADR (MGDDY), ATLANTIA SPA/ADR (ATASY), SUZUKI MTR CORP/ADR (SZKMY), KERRY GRP PLC/S (KRYAY), WIRECARD AG/ADR (WCAGY), SGS (SGSOY) and BAE SYS PLC/S (BAESY).
What other stocks do shareholders of DiaSorin own?
Who are DiaSorin's key executives?
DiaSorin's management team includes the folowing people:
- Mr. Carlo Rosa, CEO, GM & Exec. Director (Age 53)
- Dr. Chen Menachem Even, Chief Commercial Officer & Exec. Director (Age 56)
- Mr. Piergiorgio Pedron, Corp. Accounting Documents Officer, CFO & Sr. Corp. VP (Age 48)
- Mr. Riccardo Fava, Sr. Director of Investor Relations & Corp. Communication
- Mr. Marco Minolfo, Mang. of the Corp. Legal Affairs Department
How do I buy shares of DiaSorin?
Shares of DSRLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DiaSorin's stock price today?
One share of DSRLF stock can currently be purchased for approximately $114.75.
How big of a company is DiaSorin?
What is DiaSorin's official website?
How can I contact DiaSorin?
DiaSorin's mailing address is Via Crescentino, Saluggia L6, 13040. The company can be reached via phone at 390-161-4871 or via email at [email protected]
MarketBeat Community Rating for DiaSorin (OTCMKTS DSRLF)
MarketBeat's community ratings are surveys of what our community members think about DiaSorin and other stocks. Vote "Outperform" if you believe DSRLF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DSRLF will underperform the S&P 500 over the long term. You may vote once every thirty days.
